A cross-institutional team led by researchers from the Department of Electrical and Electronic Engineering (EEE), under the ...

An EDN Design Idea (DI) presented a discussion of how to increase the resolution of an ADC by adding a non-deterministic, zero-mean, Gaussian noise dither waveform to a signal to be converted; then, ...

Peripheral neuropathy (PN) is a dose-limiting side effect of chemotherapeutic and antibody drug conjugate (ADC) treatment which significantly impacts patients’ quality of life. Despite a high clinical ...

Explore how digital feedback controllers manage motors, pressure, temperature, and more, and learn why ADC and DAC performance are crucial when designing robust embedded systems. How to define the ...

Many noise sources can plague high-speed radio-frequency (RF) analog signal chains, making design considerations that much more challenging. Both megahertz and sub-terahertz sampling-rate converters ...

Agree Realty stands out as a premier net-lease REIT, boasting a high-quality, diversified portfolio anchored by investment-grade, necessity-based retail tenants. ADC's disciplined, multifaceted growth ...

While the race is on to develop antibody-drug conjugate (ADC) cancer treatments, so too is the competition to manufacture them. Hoping to gain an edge in the rapidly growing market are MilliporeSigma ...

ABSTRACT: This study introduces a Hybrid Bimodal Model for Analog-to-Digital (ADC) and Digital-to-Analog (DAC) signal conversions, addressing limitations of traditional systems, such as inefficiencies ...

ABSTRACT: This study introduces a Hybrid Bimodal Model for Analog-to-Digital (ADC) and Digital-to-Analog (DAC) signal conversions, addressing limitations of traditional systems, such as inefficiencies ...

Antibody-drug conjugates (ADCs) are a growing class of biotherapeutics that have transformed targeted therapy, especially in oncology. By making use of monoclonal antibodies’ specificity to deliver ...

The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with unresectable or metastatic hormone receptor (HR)-positive, human epidermal ...

Merck & Co. has shown off data on its ROR1-directed antibody-drug conjugate (ADC), trumpeting a 100% complete response rate but also reporting safety signals that informed the decision to take the low ...